Literature DB >> 24806433

Quantitative proteomic analysis reveals mitochondrial protein changes in MPP(+)-induced neuronal cells.

Jee Won Choi1, Min-Young Song, Kang-Sik Park.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder pathologically characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. To further explore potential functional mechanisms of PD, we performed a comparative proteomic analysis using stable isotope labeling with amino acids in cell culture (SILAC) combined with nano-LC tandem mass spectrometry (nano-LC MS). In total, 1740 proteins were identified in MPP(+)-treated SH-SY5Y cells. Our comparative proteomic analysis indicated that a total of 39 proteins were differentially expressed in SH-SY5Y cells responding to MPP(+) treatment. Of these, 14 altered proteins were clustered in the mitochondria, 5 proteins were already reported as related to PD, and the remaining proteins were newly identified in this study. Together, our data further define that the mitochondria play an important role in regulating PD through multiple and complex mechanisms and provide new insights into the functional contribution of mitochondrial proteins in PD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24806433     DOI: 10.1039/c4mb00026a

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  6 in total

1.  Chronic treatment with the complex I inhibitor MPP+ depletes endogenous PTEN-induced kinase 1 (PINK1) via up-regulation of Bcl-2-associated athanogene 6 (BAG6).

Authors:  Manish Verma; Jianhui Zhu; Kent Z Q Wang; Charleen T Chu
Journal:  J Biol Chem       Date:  2020-04-24       Impact factor: 5.157

2.  Systems biology analysis of the proteomic alterations induced by MPP(+), a Parkinson's disease-related mitochondrial toxin.

Authors:  Chiara Monti; Heather Bondi; Andrea Urbani; Mauro Fasano; Tiziana Alberio
Journal:  Front Cell Neurosci       Date:  2015-02-02       Impact factor: 5.505

3.  Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson's disease models.

Authors:  Young Cheol Kang; Minuk Son; Sora Kang; Suyeol Im; Ying Piao; Kwang Suk Lim; Min-Young Song; Kang-Sik Park; Yong-Hee Kim; Youngmi Kim Pak
Journal:  Exp Mol Med       Date:  2018-08-17       Impact factor: 8.718

4.  Bacopa Protects against Neurotoxicity Induced by MPP+ and Methamphetamine.

Authors:  Michela Ferrucci; Carla Letizia Busceti; Gloria Lazzeri; Francesca Biagioni; Stefano Puglisi-Allegra; Alessandro Frati; Paola Lenzi; Francesco Fornai
Journal:  Molecules       Date:  2022-08-15       Impact factor: 4.927

5.  Proteomic analysis reveals that the protective effects of ginsenoside Rb1 are associated with the actin cytoskeleton in β-amyloid-treated neuronal cells.

Authors:  Ji Yeon Hwang; Ji Seon Shim; Min-Young Song; Sung-Vin Yim; Seung Eun Lee; Kang-Sik Park
Journal:  J Ginseng Res       Date:  2015-10-01       Impact factor: 6.060

6.  Global analysis of ginsenoside Rg1 protective effects in β-amyloid-treated neuronal cells.

Authors:  Ji Seon Shim; Min-Young Song; Sung-Vin Yim; Seung-Eun Lee; Kang-Sik Park
Journal:  J Ginseng Res       Date:  2016-12-08       Impact factor: 6.060

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.